Cathy Gwin
Senior Director, Communications
NTI-WEF Technical Consortium for DNA Synthesis Screening Comments on Revised U.S. Government Guidance
The Technical Consortium for DNA Synthesis Screening, convened by NTI | bio and the World Economic Forum (WEF), responded to the U.S. government’s request for comment on its Revised Screening Framework Guidance for Providers and Users of Synthetic Oligonucleotides.
NTI | bio Experts in Singapore for International Conference to Strengthen Global Health Security
NTI | bio team members join hundreds of global health security experts from around the world in Singapore for the second Global Health Security Conference.
NTI | bio VP Urges Action Against Emerging Risks to Prevent Biotechnology Catastrophe
In a new article for the CTC Sentinel, NTI | bio Vice President Jaime Yassif explains how advances in bioscience and biotechnology are accompanied by emerging biological risks and cites the need for action to safeguard the life sciences to prevent biotechnology catastrophe.
NTI and WEF Convene Third Annual Meeting of DNA Synthesis Screening Technical Consortium
NTI | bio and the World Economic Forum (WEF) convened the third annual meeting of the Technical Consortium on DNA Synthesis Screening on May 12-13, 2022.
NTI | bio Experts Propose New International Organization to Address Increasing Biotechnology Risks
In a new perspective penned for Science and Diplomacy, NTI | bio’s Margaret Hamburg, Jaime Yassif, Hayley Severance and former NTI David A. Hamburg Distinguished Fellow R. Alta Charo highlight the increasing risks of accidental or deliberate misuse of modern bioscience and biotechnology, and propose the establishment of a new organization.
B-roll North Korean Nuclear Test
B-Roll IRAN Natanz Enrichment Complex
B-roll Rattehalli Materials Plant - India
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
